Screening for C9orf72 repeat expansions in parkinsonian syndromes

Neurobiol Aging. 2013 Apr;34(4):1311.e3-4. doi: 10.1016/j.neurobiolaging.2012.09.002. Epub 2012 Oct 11.

Abstract

Parkinsonism might precede, coincide, or follow the behavioral or language-predominant cognitive impairments characteristic of frontotemporal dementia (FTD). In this study, we analyze the hexanucleotide repeat expansions within C9orf72 gene in various parkinsonian syndromes because it is a recently identified important genetic cause of FTD. The expanded hexanucleotide repeat is only identified in our familial FTD patients but not in patients with predominant parkinsonism. The lack of association between abnormal C9orf72 repeat expansion and parkinsonian syndromes might imply pathogenic mechanisms other than tau or Lewy body pathology.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • C9orf72 Protein
  • DNA Repeat Expansion / genetics*
  • Genetic Markers / genetics
  • Genetic Predisposition to Disease / epidemiology*
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • Mass Screening / methods
  • Mass Screening / statistics & numerical data
  • Parkinsonian Disorders / epidemiology*
  • Parkinsonian Disorders / genetics*
  • Polymorphism, Single Nucleotide / genetics*
  • Prevalence
  • Proteins / genetics*
  • Risk Factors
  • Taiwan / epidemiology

Substances

  • C9orf72 Protein
  • C9orf72 protein, human
  • Genetic Markers
  • Proteins